Triggering role of environmental and individual factors in rheumatoid arthritis and preclinical joint symptoms
- Authors: Serdyuk I.L.1,2, Valeeva A.R.1,2, Korovina M.O.1,2, Renaudineau Y.3, Arleevskaya M.I.1,2
-
Affiliations:
- Russian Medical Academy of Continuous Professional Education
- Kazan (Volga Region) Federal University
- Universite Toulouse III — Paul Sabatier
- Issue: Vol 106, No 1 (2025)
- Pages: 51-61
- Section: Theoretical and clinical medicine
- Submitted: 13.11.2024
- Accepted: 19.12.2024
- Published: 30.12.2024
- URL: https://kazanmedjournal.ru/kazanmedj/article/view/641842
- DOI: https://doi.org/10.17816/KMJ641842
- ID: 641842
Cite item
Abstract
BACKGROUND: Rheumatoid arthritis (RA) is a phenotypically heterogeneous disease.
AIM: The study aimed to identify the role of triggers in the onset of RA and preclinical joint symptoms, as well as their association with clinical and laboratory parameters.
METHODS: Data on potential disease triggers and preclinical joint symptoms were collected from patients with early RA (n = 461) and their relatives (n = 247). Moreover, 299 healthy participants (control group) were examined for past infections within the previous 6–12 months. Anxiety levels, number of childbirths, age at onset of menopause, and body mass index (BMI) were assessed. Additionally, the association of triggers with composite disease activity indices, morning stiffness duration, severity of functional joint impairment, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) levels, anti-citrullinated peptide antibodies (ACPA), and rheumatoid factor (RF) was assessed. Data were analyzed using the Mann–Whitney test, multiple regression analysis, and Spearman correlation.
RESULTS: The most common triggers for RA and preclinical joint symptoms were menopause (17.6%, 11.7%), infections (13.4%, 15.8%), and psychological stress (15.2%, 18.2%). Preclinical joint symptoms were additionally provoked by physical exertion (19.8%). RA triggered by infections or menopause was associated with an increased frequency and duration of infections (p < 0.001) and higher BMI (p = 0.019 and p = 0.024, respectively) compared with controls. A similar association was observed between preclinical joint symptoms triggered by infections and increased frequency and duration of infections (p < 0.001). Additionally, joint symptoms triggered by physical exertion were associated with more frequent and prolonged infections compared with the control group (p = 0.015 and p = 0.016, respectively). ESR levels exhibited a heightened response when preclinical joint symptoms were associated with infections (p = 0.010), menopause (p = 0.033), or physical exertion (p = 0.020) in comparison with their response to psychological stress. The arthralgia score was highest when provoked by menopause compared with cases provoked by infection (p = 0.053) or childbirth (p = 0.012). Preclinical joint symptoms triggered by psychological stress were associated with a higher arthralgia score than those provoked by physical exertion (p = 0.002). In the preclinical group, ESR and CRP levels correlated with BMI (p = 0.005 and p = 0.028, respectively). In patients with RA, ACPA (p = 0.044) and RF (p = 0.009) concentrations were associated with personal anxiety levels.
CONCLUSION: The influence of triggers on clinical and laboratory parameters is evident in preclinical RA. The highest arthralgia scores were observed in cases triggered by menopause or psychological stress. Joint symptoms associated with infections, menopause, or physical exertion were associated with higher ESR levels.
Full Text

About the authors
Igor L. Serdyuk
Russian Medical Academy of Continuous Professional Education; Kazan (Volga Region) Federal University
Email: dr.serdyuc@mail.ru
ORCID iD: 0000-0002-9890-3755
SPIN-code: 4067-5062
Kazan State Medical Academy — branch of the Russian Medical Academy of Continuous Professional Education; laboratory assistant, Central research laboratory, Assistant Professor, Depart. of Internal Medicine, Institute of Fundamental Medicine and Biology
Russian Federation, 11 Mushtary street, 420012 Kazan; KazanAnna R. Valeeva
Russian Medical Academy of Continuous Professional Education; Kazan (Volga Region) Federal University
Email: anna-valeeva@mail.ru
ORCID iD: 0000-0001-5218-9341
SPIN-code: 4922-7323
Kazan State Medical Academy — branch of the Russian Medical Academy of Continuous Professional Education; Cand. Sci. (Medicine), Senior Researcher, Central research laboratory, Senior lecturer, Depart. of Applied Ecology, Institute of Ecology, Biotechnology and Nature Management
Russian Federation, 11 Mushtary street, 420012 Kazan; KazanMarina O. Korovina
Russian Medical Academy of Continuous Professional Education; Kazan (Volga Region) Federal University
Email: koporulina.mo@gmail.com
ORCID iD: 0000-0002-2307-928X
SPIN-code: 1756-6530
Kazan State Medical Academy — branch of the Russian Medical Academy of Continuous Professional Education; Researcher, Central research laboratory, Postgraduate student, Depart. of Biochemistry, Biotechnology and Pharmacology Institute of Fundamental Medicine and Biology
Russian Federation, 11 Mushtary street, 420012 Kazan; KazanYves Renaudineau
Universite Toulouse III — Paul Sabatier
Email: renaudineau.y@chu-toulouse.fr
ORCID iD: 0000-0001-5098-5002
Dr. Sci. (Pharmacy), Professor, Depart. of Immunology
France, ToulouseMarina I. Arleevskaya
Russian Medical Academy of Continuous Professional Education; Kazan (Volga Region) Federal University
Author for correspondence.
Email: marleev@mail.ru
ORCID iD: 0000-0002-0584-446X
SPIN-code: 2513-6093
Kazan State Medical Academy — branch of the Russian Medical Academy of Continuous Professional Education; Cand. Sci. (Medicine), Senior Researcher, Central research laboratory, Associate Professor, Depart. of Internal Medicine, Institute of Fundamental Medicine and Biology
Russian Federation, 11 Mushtary street, 420012 Kazan; KazanReferences
- Petrovská N, Prajzlerová K, Vencovský J, et al. The pre-clinical phase of rheumatoid arthritis: From risk factors to prevention of arthritis. Autoimmun Rev. 2021,20(5):102797. doi: 10.1016/j.autrev.2021.102797
- Arleevskaya M, Takha E, Petrov S, et al. Interplay of Environmental, Individual and Genetic Factors in Rheumatoid Arthritis Provocation. Int J Mol Sci. 2022;23(15):8140. doi: 10.3390/ijms23158140
- Jonsson H, Helgason J. Rheumatoid Arthritis in an Icelandic Textbook from 1782. Scand J Rheum. 1996;25(3):134–137. doi: 10.3109/03009749609080002
- Weyand CM, Klimiuk PA, Goronzy JJ. Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes. Springer Semin Immunopathol. 1998;20(1–2):5–22. doi: 10.1007/BF00831996
- Kay J, Upchurch KS. ACR/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology. 2012;51(suppl 6):vi5–vi9. doi: 10.1093/rheumatology/kes279
- Arnett FC, Edworthy SM, Bloch DA, et al. The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–24. doi: 10.1002/art.1780310302
- Gerlag DM, Razaet K, Van Baarsen LGM, et al. EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann Rheum Dis. 2012;71(5):638–41. doi: 10.1136/annrheumdis-2011-200990
- Arleevskaya MI, Novikov AA, Valeeva AR, et al. At Early Rheumatoid Arthritis Stage, the Infectious Spectrum Is Driven by Non-Familial Factors and Anti-CCP Immunization. J Clin Med. 2024;13(10):2796. doi: 10.3390/jcm13102796
- Rheumatoid arthritis. Clinical guidelines of the Ministry of Health of Russia. 2021. Available from: https://cr.minzdrav.gov.ru/schema/250_2 (In Russ.)
- Ruta S, Prado ES, Chichande JT, et al. EULAR definition of “arthralgia suspicious for progression to rheumatoid arthritis” in a large cohort of patients included in a program for rapid diagnosis: role of auto-antibodies and ultrasound. Clin Rheum. 2020;39(5):1493–9. doi: 10.1007/s10067-019-04855-0
- Spielberger CD, Vagg PR. Test anxiety: A transactional process model. In: Spielberger CD, Vagg PR, editors. Test anxiety: Theory, assessment, and treatment. Washington DC: Taylor & Francis; 1995. P. 3–14.
- Ruzzon F, Adami G. Environment and arthritis. Clin Exp Rheum. 2024;42(7):1343–1349. doi: 10.55563/clinexprheumatol/z7lkua
- Tuaeva NO, Nosyrev AE, Renaudineau Y, Arleevskaya MI. Psychological stress and rheumatoid arthritis – interference of pathogenetic mechanisms. Rheumatology Science and Practice. 2019;57(1):83–90. doi: 10.14412/1995-4484-2019-83-90
- Carroll JE, Carrillo C, Olmstead R, et al. Sleep Deprivation and Divergent Toll-like Receptor-4 Activation of Cellular Inflammation in Aging. Sleep. 2015;38(2):205–11. doi: 10.5665/sleep.4398
- Dolsen EA, Crosswell AD, Prather AA. Links Between Stress, Sleep, and Inflammation: Are there Sex Differences? Curr Psychiatry Rep. 2019;21(2):8. doi: 10.1007/s11920-019-0993-4
- Morgan E, Schumm LP, McClintock M, et al. Sleep Characteristics and Daytime Cortisol Levels in Older Adults. Sleep. 2017;40(5):1–11. doi: 10.1093/sleep/zsx043
Supplementary files
